FP7
Université Lille 2 Droit et Santé
- Country
- FRFrance
- Defence projects
- 0
- Projects, all programmes
- 14
- As coordinator
- 1
- EU contribution (CORDIS)
- EUR 5,629,989
- Active
- 2008 to 2014
Projects
14 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| BETACUREPersonalized diagnosis and treatment of hyperinsulinemic hypoglycaemia caused by beta-cell pathology | FP7 | 2014 | Participant | EUR 250,000 |
| UNIVACFLUUniversal Flu Vaccine | FP7 | 2013 | Participant | EUR 430,981 |
| IMPROVINGADHERENCEImproving medical treatment adherence : taking into account patients' perception of uncertainty in the causal relationship between their adherence behaviour and their health condition | FP7 | 2012 | Coordinator | EUR 75,000 |
| GEPIDIABGenetics and epigenetics of Type 2 Diabetes physiology | FP7 | 2012 | Participant | EUR 995,107 |
| VALUESValue Analysis of Local Utilities of Enterprises from Social sector | FP7 | 2012 | Participant | EUR 7,600 |
| CONSIDERCIVIL SOCIETY ORGANISATIONS IN DESIGNING RESEARCH GOVERNANCE | FP7 | 2012 | Participant | EUR 319,480 |
| EURHYTHDIAChronotherapeutic lifestyle intervention for diabetes and obesity to reset the circadian rhythm and improve cardiometabolic risk in the European working population | FP7 | 2011 | Participant | EUR 790,519 |
| Commodity12COntinuous Multi-parametric and Multi-layered analysis Of DIabetes TYpe 1 & 2 | FP7 | 2011 | Participant | EUR 17,401 |
| FULL4HEALTHUnderstanding food-gut-brain mechanisms across the lifespan in the regulation of hunger and satiety for health | FP7 | 2011 | Participant | EUR 354,000 |
| BETACELLTHERAPYBeta Cell Therapy in Diabetes | FP7 | 2010 | Participant | EUR 402,000 |
| PHARMA-COGPrediction of cognitive properties of new drug candidates for neurodegenerative diseases in the early clinical development | FP7 | 2010 | Participant | EUR 1,066,828 |
| ALLFUNFungi in the setting of inflammation, allergy and autoimmune diseases:Translating basic science into clinical practices | FP7 | 2010 | Participant | EUR 501,073 |
| PSIPPATIENT SAFETY THROUGH INTELLIGENT PROCEDURES IN MEDICATION | FP7 | 2008 | Participant | EUR 0 |
| MEMOSADMemory loss in Alzheimer disease: underlying mechanisms and therapeutic targets | FP7 | 2008 | Participant | EUR 420,000 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.